Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26–27 April 2004, Bangkok, Thailand
- 15 April 2005
- Vol. 23 (21) , 2689-2695
- https://doi.org/10.1016/j.vaccine.2004.11.040
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman PrimatesJournal of Virology, 2004
- Relationship of Preexisting Dengue Virus (DV) Neutralizing Antibody Levels to Viremia and Severity of Disease in a Prospective Cohort Study of DV Infection in ThailandThe Journal of Infectious Diseases, 2004
- Alterations of pr-M Cleavage and Virus Export in pr-M Junction Chimeric Dengue VirusesJournal of Virology, 2004
- Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai childrenThe Pediatric Infectious Disease Journal, 2004
- PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINEThe American Journal of Tropical Medicine and Hygiene, 2003
- Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine DevelopmentJournal of Virology, 2003
- Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysVaccine, 2003
- A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in MonkeysJournal of Virology, 2003
- Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in MonkeysJournal of Virology, 2002
- Dengue: an updateThe Lancet Infectious Diseases, 2002